This ETF offers 2x daily short leverage to the broad-based NASDAQ Biotechnology Index, making it a powerful tool for investors with a bearish short-term outlook for biotechnology or pharmaceuticals companies. Investors should note that BIS's leverage resets on a daily basis, which results in compounding of returns when held for multiple periods. BIS can be a powerful tool for sophisticated investors, but should be avoided by those with a low risk tolerance or a buy-and-hold strategy.
|Day Lo||-||Day Hi||-|
This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.
This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.
View charts featuring ETF fund flow data.5 Day Net Flows: -1.12 M 1 Month Net Flows: -2.22 M 3 Month Net Flows: -986.69 K 6 Month Net Flows: -340.55 K 1 Year Net Flows: 3.71 M 3 Year Net Flows: -2.5 M 5 Year Net Flows: -18.59 M 10 Year Net Flows: 86.28 M
The adjacent table gives investors an individual Realtime Rating for BIS on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Leveraged Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
This section shows how this ETF has performed relative to its peer group ETFdb.com Category.
This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.